Business model

AVATAi Revolutionizes 3D Creation with New Generative AI Platform

An accessible generative AI platform unleashing a new wave of digital creativity—launching December 18

12-18 AVATAi Sdn Bhd

aiMotive and Safran collaborate to make ADAS & AD development safer

MOUNTAIN VIEW,Calif.,Dec. 17,2024-- aiMotive,a leading provider of cutting-edge simulation and AI technologies,has joined forces with Safran Electronics & Defense to advance the testing and valid

12-18 aiMotive

Origin Agritech Holds Successful 2025 R&D and Business Management Conference

BEIJING,Dec. 17,2024-- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"),a leading Chinese agricultural technology company,recently held its 2025 R&D and Business

12-18 Origin Agritech Limited

Dean Wilkinson Joins Private Equity backed DanMagi as Executive Chairman, Bringing Extensive Industry Expertise and Vision for Growth

COPENHAGEN,Denmark,Dec. 17,2024-- DanMagiis pleased to announce the appointment of Dean Wilkinson as a pivotal addition to the company leadership. With an impressive 16-year track record in the techno

12-18 DanMagi ApS

Xiao-I Corporation Forecasts $12-15 Million in New Revenue in 2025 from AI Glasses Driven by Strong Demand and Central Procurement Invitations

ROCKVILLE,Md.,Dec. 17,2024-- Xiao-I Corporation (NASDAQ: AIXI),a leading artificial intelligence company ("Xiao-I"),today announced significant milestones in expanding its U.S. presence and

12-18 Xiao I Corporation

Automation Anywhere Secures Leadership in Agentic Process Automation, Posts Fifth Consecutive Quarter of Profitable and YoY Growth

Highest non-GAAP profitable quarter,increasing customer demand driving growth in AI Agent transactions solidifying its position as #1 Agentic Process Automation Platform

12-18 Automation Anywhere, Inc.

Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients

SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm

12-18 Everest Medicines

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

- Samsung Life Science Fund invests inGenerate:Biomedicines,a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development

12-18 Samsung Biologics

MONOPOLY DREAMS™ HONG KONG FESTIVE TREATS FOR FESTIVE DREAMS WITH FAMILIES, FRIENDS & FANS

Exclusive Christmas Package Offer Starting from $499 For Two to $699 For Three HONG KONG,Dec. 18,2024-- MONOPOLY DREAMSTMHong Kong offers to magnify your festive excitement with its exclusive Christma

12-18 Monopoly Dreams

GRAVITY GAME HUB REVEALS RAGNAROK IDLE ADVENTURE CLOSED BETA DATE

SINGAPORE,Dec. 18,2024-- Gravity Game Hub (GGH) PTE.LTD,a subsidiary of GRAVITY Co.,Ltd. (NasdaqGM: GRVY) has announced the start of CBT Registration for its widely anticipated AFK mobile game,Ragnaro

12-18 Gravity Game Hub (GGH) Pte. Ltd.